The relationship of the mean platelet volume and C-reactive protein levels with mortality in ischemic stroke patients

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 13, 2013, Pages 1774-1777

  Arikanoglu, A ^a   Yucel, Y ^a   Acar, A ^a   Cevik, M U ^a   Akil, E ^a   Varol, S ^a   Unan, F ^a   Tasdemir, N ^a  

^a DICLE UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

C reactive protein; Mean platelet volume; Mortality; Stroke

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; DISEASE MARKER; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; STROKE PATIENT; SURVIVAL; THROMBOCYTE COUNT; THROMBOCYTE VOLUME; AGED; BLOOD; BLOOD CELL COUNT; CEREBROVASCULAR ACCIDENT; METABOLISM; MIDDLE AGED;

AGED; BLOOD CELL COUNT; BLOOD SEDIMENTATION; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; PLATELET COUNT; STROKE;

EID: 84884181235     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. BATH PM, BUTTERWORTH RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996; 7: 157-161.
2. ENDLER G, KLIMESCH A, SUNDER-PLASSMANN H, SCHILLINGER M, EXNER M, MANNHALTER C, JORDANOVA N, CHRIST G, THALHAMMER R, HUBER K, SUNDER-PLASSMANN R. Mean platelet volume is an independent risk factor for myocardial infarction but for coronary artery disease. Br J Haematol 2002; 117: 399-404.
3. KURABAYASHI H, TAMURA J, NARUSE T, KUBOTA K. Possible existence of platelet activation before onset of cerebral infarction. Atherosclerosis 2000; 153: 203-207.
4. TSCHOEPE D, ROESEN P, ESSER J, SCHWIPPERT B, NIEUWENHUIS HK, KEHREL B, GRIES FA. Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 1991; 17: 433-438.
5. GREISENEGGER S, ENDLER G, HSIEH K, TENTSCHERT S, MANNHALTER C, LALOUSCHEK W. Is elevated mean platelet volume associated with a worse outcome in patients with acute ischemic cerebrovascular events? Stroke 2004; 35: 1688-1691.
6. MAYDA-DOMAÇ F, MISIRLI H, AND YILMAZ M. Prognostic role of mean platelet volume and platelet count in ?schemic and hemorrhagic stroke. J Stroke Cerebrovasc Dis 2010; 19: 66-72.
7. NTAIOS G, GURER O, FAOUZI M, AUBERT C, MICHEL P. Mean platelet volume in the early phase of acute ischemic stroke is not associated with severity or functional outcome.Cerebrovasc Dis 2010; 29: 484-489.
8. GÜLDIKEN B, ÖZKAN H, KABAYEL L. Mean platelet volume and peripheral blood count response in acute ?schemic stroke. Balkan Med J 2008; 25: 130-135.
9. DIRNAGL U, IADECOLA C, MOSKOWITZ MA. Pathobiology of ischaemic stroke: an integrated view. Trends Neurosci 1999; 22: 391-397.
10. SHANTIKUMAR S, GRANT PJ, CATTO AJ, BAMFORD JM, CARTER AM. Elevated C-reactive protein and longterm mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation. Stroke 2009; 40: 977-979.
11. CORSO G, BOTTACCHI E, BRUSA A, DI BENEDETTO M, GIARDINI G, LIA C, REGGIANI M, VERONESE MOROSINI M. Is there a prognostic role for C-reactive protein in ischemic stroke? Acta Neurol Scand 2010: 122: 209-216.
12. CANOVA CR, COURTIN C, REINHART WH. C-reactive protein in cerebrovascular events. Atherosclerosis 1999; 147: 49-53.
13. LIBBY P, SIMON DI. Inflammation and thrombosis: the clot thickens.Circulation 2001; 103: 1718-1720.
14. BISOENDIAL RJ, KASTELEIN JJ, LEVELS JH, ZWAGINGA JJ, VAN DEN BOGAARD, B REITSMA, PH MEIJERS, JC, HARTMAN D, LEVI M, STROES, ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circulation Res 2005; 96; 714-716.
15. DANENBERG HD, KANTAK N, GRAD E, SWAMINATHAN RV, LOTAN C, EDELMAN ER. C-reactive protein promotes monocyte-platelet aggregation: an additional link to the inflammatory-thrombotic intricacy. Eur J Haematol 2007; 78: 246-252.
16. MARTIN JF, SHAW T, HEGGIE J, PENINGTON DG. Measurement of the density of platelets and its relationship to volume. Br J Haematol 1983; 54: 337-352.
17. KRISTENSEN SD.The platelets vessel wall interaction in experimental atherosclerosis and ischemic heart disease with special reference to thrombopoiesis. Dan Med Bull 1992; 39: 110-127.
18. MARTIN JF, BATH PM, BURR ML.Mean platelet volume and myocardial infarction.Lancet 1992;339:1409-1411.
19. BILJAK VR, PANCIROV D, CEPELAK I, POPOVIC-GRLE S, STJEPANOVIC G, GRUBISIC TZ. Platelet count, mean platelet volume and smoking status in stable chronic obstructive pulmonary disease. Platelets 2011; 22: 466-470.
20. BARTOSIK-PSUJEK H, BELNIAK E, STELMASIAK Z. Markers of inflamation in cerebral ischemia. Neurol Sci 2003; 24: 279-280.
21. ELKIND MS, COATES K, TAI W, PAIK MC, BODEN-ALBALA B, SACCO RL. Levels of acute phase proteins remain stable after ischemic stroke.BMC Neurol 2006; 16: 37.
22. DI NAPOLI M, PAPA F, BOCOLA V. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke. Stroke 2001; 32: 133-138.
23. PURROY F, MONTANER J, MOLINA CA DELGADO P, ARENILLAS JF, CHACON P, QUINTANA M, ALVAREZ-SABIN J. Creactive protein predicts further ischemic events in transient ischemic attack patients. Acta Neurol Scand 2007; 115: 60-66.
24. VAN DER MEER IM, DE MAAT MP, HAK AE, KILIAAN AJ, DEL SOL AI, VAN DER KUIP DA, NIJHUIS RL, HOFMAN A, WITTEMAN JC. C-reactive protein predicts progression of atherosclerosis measure at various sites in the arterial tree: the Rotterdam Study. Stroke 2002; 33: 2750-2755.
25. WANG TJ, NAM BH, WILSON PW, WOLF PA, LEVY D, POLAK JF, D'AGOSTINO RB, O'DONNELL CJ. Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study. Arterioscler Thromb Vasc Biol 2002; 22: 1662-1667.
26. FOLSOM AR, PANKOW JS, TRACY RP, ARNETT DK, PEACOCK JM, HONG Y, DJOUSSÉ L, ECKFELDT JH. Association of Creactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001; 88: 112-117.
27. GRAD E, PACHINO RM, DANENBERG HD. Endothelial Creactive protein increases platelet adhesion under flow conditions. Am J Physiol Heart Circ Physiol 2011; 301: 730-736.